Evidence map›Paper›PMID 34536012›Full record

ArticleSchizophrenia bulletin2022

Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.

Nina Zaks, Tjasa Velikonja, Muhammad A Parvaz, Jamie Zinberg, Monica Done, Daniel H Mathalon, Jean Addington, Kristin Cadenhead, Tyrone Cannon, Barbara Cornblatt and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 3 countries.

Nina ZaksDepartment of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.
Tjasa VelikonjaDepartment of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.
Muhammad A ParvazDepartment of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.
Jamie ZinbergDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Monica DoneDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Daniel H MathalonSan Francisco VA Health Care System.
Jean AddingtonHotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Kristin CadenheadDepartment of Psychiatry, University of California San Diego (UCSD), La Jolla, CA, USA.ORCID 0000-0002-5952-4605
Tyrone CannonDepartments of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Barbara CornblattDepartment of Psychology, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, USA.
Thomas McGlashanDepartments of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Diana PerkinsDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
William S StoneHarvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0003-2932-7288
Ming TsuangDepartment of Psychiatry, University of California San Diego (UCSD), La Jolla, CA, USA.
Elaine WalkerDepartment of Psychology, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-9798-8101
Scott W WoodsDepartments of Psychiatry and Psychology, Yale University, New Haven, CT, USA.
Matcheri S KeshavanHarvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, USA.
Daniel J BuysseUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-3288-1864
Eva VelthorstDepartment of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.
Carrie E BeardenDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.ORCID 0000-0002-8516-923X
Icahn School of Medicine at Mount Sinai · USUniversity of California, Los Angeles · USYale University · USBeth Israel Deaconess Medical Center · USUniversity of California San Diego · USAnna Freud Centre · GBEmory University · USFeinstein Institute for Medical Research · USUniversity of Calgary · CAUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Subject Management and BiobankingP50DA046346 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Daniel J. Buysse, Colleen A McClung · 2020 to 2026
$23.4M
Training and DisseminationP41EB015902 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI KIKINIS, RON, WESTIN, CARL-FREDRIK · 2012 to 2022
$20.9M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
Novel DT-MRI Analyses of White Matter in SchizophreniaR01MH074794 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI WESTIN, CARL-FREDRIK · 2007 to 2021
$9.6M
5/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082004 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PERKINS, DIANA O. · 2008 to 2018
$7.5M
Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
6/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081944 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CADENHEAD, KRISTIN S. · 2008 to 2018
$4.9M
"7/9" Predictors and Mechanisms of Conversion to PsychosisU01MH081984 · NIMH · UNIVERSITY OF CALGARY · PI ADDINGTON, JEAN M · 2008 to 2018
$4.2M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS UH3 HL125103NIBIB NIH HHS P41 EB015902NIDA NIH HHS K01 DA043615NIDA NIH HHS P50 DA046346NIMH NIH HHS R01 MH074794NIMH NIH HHS R01 MH102377NIMH NIH HHS R01 MH108574NIMH NIH HHS U01 MH076989NIMH NIH HHS U01 MH081857NIMH NIH HHS U01 MH081902NIMH NIH HHS U01 MH081928NIMH NIH HHS U01 MH081944NIMH NIH HHS U01 MH081984NIMH NIH HHS U01 MH081988NIMH NIH HHS U01 MH082004NIMH NIH HHS U01 MH082022
6 · The paper itself

Abstract

introductionDisturbed sleep is a common feature of psychotic disorders that is also present in the clinical high risk (CHR) state. Evidence suggests a potential role of sleep disturbance in symptom progression, yet the interrelationship between sleep and CHR symptoms remains to be determined. To address this knowledge gap, we examined the association between disturbed sleep and CHR symptoms over time.

methodsData were obtained from the North American Prodrome Longitudinal Study (NAPLS)-3 consortium, including 688 CHR individuals and 94 controls (mean age 18.25, 46% female) for whom sleep was tracked prospectively for 8 months. We used Cox regression analyses to investigate whether sleep disturbances predicted conversion to psychosis up to >2 years later. With regressions and cross-lagged panel models, we analyzed longitudinal and bidirectional associations between sleep (the Pittsburgh Sleep Quality Index in conjunction with additional sleep items) and CHR symptoms. We also investigated the independent contribution of individual sleep characteristics on CHR symptom domains separately and explored whether cognitive impairments, stress, depression, and psychotropic medication affected the associations.

resultsDisturbed sleep at baseline did not predict conversion to psychosis. However, sleep disturbance was strongly correlated with heightened CHR symptoms over time. Depression accounted for half of the association between sleep and symptoms. Importantly, sleep was a significant predictor of CHR symptoms but not vice versa, although bidirectional effect sizes were similar. DISCUSSION: The critical role of sleep disturbance in CHR symptom changes suggests that sleep may be a promising intervention target to moderate outcome in the CHR state.

Indexed as

Disease ProgressionProdromal SymptomsPsychotic DisordersSchizophreniaSleep Wake DisordersAdolescentAdultFemaleHumansLongitudinal StudiesMaleNorth AmericaPrognosisRiskYoung Adultprodromepsychotic disordersschizophreniaultra-high risk

Identifiers

PMID34536012
PMCPMC8781348
OpenAlexW3199925085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.